跳至主要内容
临床试验/NCT01956370
NCT01956370已完成2 期

Phase II - Evaluation of Safety and Efficacy of the PrePexTM Device for Rapid Scale up of Adult Male Circumcision Programs in Zimbabwe (Comparative Study)

Ministry of Health and Child Welfare, Zimbabwe1 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2011年11月1日最近更新:
适应症

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
240
试验地点
1
主要终点
Procedure time

研究概览

简要总结

The protocol, approved by the Medical Research Council, was issued to assess the safety and efficacy of the non-surgical device for applying it to the national scale up of adult male circumcision in Zimbabwe

详细描述

Models show that to have the highest impact on the HIV epidemic, circumcision of up to 80% of men in high prevalence countries, where MC rates are low, needs to be achieved (UNAIDS 2009; Manicaland HIV/STD Prevention Project, 2008; Bollinger, et al, 2009). Hallett and colleagues in 2008 showed that for Zimbabwe specifically, HIV incidence could be reduced between 25% to 35% if about 50% of men are circumcised. All modelings conducted show that MC programs must be part of a comprehensive HIV prevention package as MC alone will not tip the HIV epidemic into a terminal decline.

The PrePex Device offers hope for rapid scale up of adult male circumcision in resource limited settings.

Once the safety and efficacy have been established, it is important to conduct operations research to determine how best to implement both device and surgical circumcisions in the national program. Thus, the Zimbabwe MOHCW is planning a three phase trial in order to determine the safety of the PrePexTM device, its performance and the ease of use in an implementation roll out.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 30 Years(Adult)
性别
Male
接受健康志愿者

入选标准

  • Ages 18 - 30 years
  • Uncircumcised
  • Wants to be circumcised
  • Agrees to be circumcised by any of the study methods,PrePexTM or Surgical as appropriate
  • HIV sero-negative
  • Able to understand the study procedures and requirements
  • Agrees to abstain from sexual intercourse and to keep caution not to directly rub the cut area if masturbating, for 8 weeks post removal (9 weeks total)
  • Agrees to return to the health care facility for follow-up visits (or as instructed) after his circumcision for a period of 8 weeks post removal (9 weeks total)
  • Subject able to comprehend and freely give informed consent for participation in this study and is considered by the investigator to have good compliance for the study
  • Subject agrees to anonymous video and photographs of the procedure and follow up visits
  • Agrees to stay overnight at the Hospital in order to follow pain measurements in the first 16 hours

排除标准

  • Active genital infection, anatomic abnormality or other condition, which in the opinion of the investigator prevents the subject from undergoing a circumcision
  • HIV sero-positive
  • Subject with the following diseases/conditions: phimosis, paraphimosis, warts under the prepuce, torn or tight frenulum, narrow prepuce, hypospadias, epispadias
  • Known bleeding / coagulation abnormality
  • Uncontrolled diabetes
  • Subject that to the opinion of the investigator is not a good candidate
  • Subject does not agree to anonymous video and photographs of the procedure and follow up visits
  • Refusal to take HIV test.

结局指标

主要结局

Procedure time

时间窗: 9 weeks

To compare the total operative time of the PrePex Device circumcision procedure versus the total operative time of surgical circumcision procedure.

次要结局

  • Perception of norms(9 weeks)
  • Sharing information with family and friends(9 weeks)
  • Expectations of men regarding the procedure(9 weeks)
  • Satisfaction rate of the procedure(9 weeks)
  • Attitudes towards procedure(9 weeks)
  • Sexual relations, performance, satisfaction(9 weeks)
  • Sexual behavior(9 weeks)
  • Effect on daily activities(9 weeks)
  • Sexual partner's attitudes(9 weeks)
  • Cost-effectiveness(9 weeks)
  • Costs(9 weeks)

研究者

发起方
Ministry of Health and Child Welfare, Zimbabwe
申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Mufuta Tshimanga

Public Health Physician, Department of Community Medicine, University of Zimbabwe

Ministry of Health and Child Welfare, Zimbabwe

研究点 (1)

Loading locations...

相似试验